RICERCA
AUTORI
RIVISTE
Sfoglia per AUTORE
FENOGLIO R
Collezione ASL Città di Torino
Items : 85
Efficacy and Safety of Ravulizumab in IgA Nephropathy: A Phase 2 Randomized Double-Blind Placebo-Controlled Trial. in Journal of the American Society of Nephrology : JASN / J Am Soc Nephrol. 2024 Oct 25. doi: 10.1681/ASN.0000000534.
2024
ASL Città di Torino
Rice K; Barratt J; Garlo K; Kateifides A; Yee M; Susan Huang SH; Alamartine E; Kim SG; Wu MS; Pérez Valdivia MÁ; Kaufeld J; Fenoglio R; Tumlin J; Lafayette R;
The role of kidney biopsy in the diagnosis of membranous nephropathy. in Clinical kidney journal / Clin Kidney J. 2024 Oct 3;17(10):sfae292. doi: 10.1093/ckj/sfae292. eCollection 2024 Oct.
2024
ASL Città di Torino
Sciascia S; Fenoglio R; Roccatello D;
Extremely Long-Lasting B-cell Depletion and BAFFling Effects Following Obinutuzumab-Based Regimen in Lupus Nephritis. in Kidney international reports / Kidney Int Rep. 2024 Aug 10;9(10):3079-3080. doi: 10.1016/j.ekir.2024.08.008. eCollection 2024 Oct.
2024
ASL Città di Torino
Fenoglio R; Martins E; Mao HA; Rossi D; Schindler T; De Simone E; Sciascia S; Roccatello D;
AKI Associated with Anti-cancer Therapies: Small Molecules and Targeted Therapies. in Kidney360 / Kidney360. 2024 Aug 26. doi: 10.34067/KID.0000000566.
2024
ASL Città di Torino
Cosmai L; Joseph T; Pirovano M; Fenoglio R; Kala J;
Assessing the steroid-sparing effect of biological agents in randomized controlled trials for lupus: a scoping review. in Immunologic research / Immunol Res. 2024 Aug;72(4):538-553. doi: 10.1007/s12026-024-09463-y. Epub 2024 Mar 9.
2024
ASL Città di Torino
Roccatello D; Fenoglio R; Barinotti A; Cecchi I; Radin M; Foddai SG; Arbrile M; Sciascia S;
Safety and efficacy of pre-exposure prophylaxis with tixagevimab/cilgavimab (Evusheld) in patients with glomerular diseases who received rituximab. in Clinical kidney journal / Clin Kidney J. 2023 May 15;16(9):1465-1468. doi: 10.1093/ckj/sfad111. eCollection 2023 Sep.
2023
ASL Città di Torino
Roccatello D; Menegatti E; Baldovino S; Barinotti A; Guidetti MG; Cinnirella G; Crosasso P; Cecchi I; Radin M; Foddai SG; Fenoglio R; Rilat MLA; Sciascia S;
[Management of Cast Nephropathy]. in Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia / G Ital Nefrol. 2023 Oct 3;40(Suppl 81):2023-S81.
2023
ASL Città di Torino
Roccatello D; Sciascia S; Bugliosi F; Geraci G; Careddu A; Cortazzi S; Fenoglio R; De Simone E;
[Renal Side Effects of Novel Molecular Targeted Oncologic Agents]. in Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia / G Ital Nefrol. 2023 Oct 3;40(Suppl 81):2023-S81.
2023
ASL Città di Torino
Roccatello D; Sciascia S; Marchisio M; Terzolo E; Rabajoli G; Cortazzi S; Fenoglio R;
[Renal Replacement Therapy in Cancer Patients with AKI]. in Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia / G Ital Nefrol. 2023 Oct 3;40(Suppl 81):2023-S81.
2023
ASL Città di Torino
Pozzato M; Fenoglio R; Caruso N; Ceruti C; Amore G; Sciascia S; Roccatello D;
[Management of the Oncological Patient with Chronic Renal Failure]. in Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia / G Ital Nefrol. 2023 Oct 3;40(Suppl 81):2023-S81.
2023
ASL Città di Torino
Fenoglio R; Cortazzi S; Guarino A; Longo R; Caniggia I; Sciascia S; Roccatello D;
[Cancer and the Kidney: A Deadly Embrace]. in Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia / G Ital Nefrol. 2023 Oct 3;40(Suppl 81):2023-S81.
2023
ASL Città di Torino
Fenoglio R; Sciascia S; Nescis L; La Rosa A; Roccatello D; Bertinetto F; Cortazzi S;
[Onconefrologia: una sfida]. in Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia / G Ital Nefrol. 2023 Oct 3;40(Suppl 81):2023-S81.
2023
ASL Città di Torino
Roccatello D; Fenoglio R; La Manna G;
Relevance of next generation sequencing (NGS) data re-analysis in the diagnosis of monogenic diseases leading to organ failure. in BMC medical genomics / BMC Med Genomics. 2023 Nov 27;16(1):303. doi: 10.1186/s12920-023-01747-w.
2023
AOU Città della Salute di Torino
ASL Città di Torino
Bracciamà V; Vaisitti T; Deaglio S; Roccatello D; Alberti C; Amoroso A; Carli D; Fenoglio R; Mussa A; Calvo PL; Peruzzi L; Kalantari S; Luca M; Romeo CM; Scolari C; Mioli F; Faini AC; Brach Del Prever GM; Saglia C; Trotta L;
The steroid-sparing effects of a mycophenolate mofetil-based regimen in the management of immunoglobulin A nephropathy in patients with histologically active lesions: A comparison with a control cohort receiving conventional therapy. in Journal of nephrology / J Nephrol. 2023 Nov;36(8):2223-2231. doi: 10.1007/s40620-023-01636-6. Epub 2023 Jun 12.
2023
ASL Città di Torino
Sciascia S; Fenoglio R; Quattrocchio G; Roccatello D; Careddu A; Naretto C; Ferro M;
Open-label, prospective, phase II descriptive pilot trial of belimumab therapy for refractory and/or non-criteria manifestations of antiphospholipid syndrome: study protocol. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2023 Mar;41(3):597-604. doi: 10.55563/clinexprheumatol/qa2yb4. Epub 2022 Oct 28.
2023
ASL Città di Torino
Roccatello D; Menegatti E; Vaccarino A; Fenoglio R; Rossi D; Rubini E; Barinotti A; Cecchi I; Radin M; Sciascia S;
Semi-selective plasma filtration applied to the treatment of acquired thrombotic thrombocytopenic purpura following bnt162b2 administration. in Journal of nephrology / J Nephrol. 2023 Jan;36(1):229-232. doi: 10.1007/s40620-022-01402-0. Epub 2022 Sep 3.
2023
ASL Città di Torino
Roccatello D; Quattrocchio G; Baffa A; Marchisio M; Fenoglio R;
Refractory Systemic Lupus Erythematosus: Identification and Pharmacological Management. in Drugs / Drugs. 2023 Feb;83(2):117-134. doi: 10.1007/s40265-022-01824-x. Epub 2023 Feb 2.
2023
ASL Città di Torino
Fenoglio R; Rossi D; Sciascia S; Roccatello D;
Daratumumab monotherapy for refractory lupus nephritis. in Nature medicine / Nat Med. 2023 Aug;29(8):2041-2047. doi: 10.1038/s41591-023-02479-1. Epub 2023 Aug 10.
2023
ASL Città di Torino
Sciascia S; Cozzi M; Del Vecchio G; De Simone E; Rossi D; Rubini E; Cecchi I; Naretto C; Roccatello D; Fenoglio R; Kamgaing J; Caniggia I;
Focal segmental glomerular sclerosis can be effectively treated using an intensive B-cell depletion therapy. in Clinical kidney journal / Clin Kidney J. 2022 Sep 12;16(8):1258-1264. doi: 10.1093/ckj/sfac207. eCollection 2023 Aug.
2023
ASL Città di Torino
ASL Biella
AOU Città della Salute di Torino
Cravero R; Roscini E; Roccatello D; Baffa A; Naretto C; Fenoglio R; Sciascia S; Barreca A;
Chasing the Zebra: a case of membranous-like Glomerulopathy with SSA/RO52 deposits and no overt connective tissue disease. in BMC rheumatology / BMC Rheumatol. 2023 Apr 5;7(1):6. doi: 10.1186/s41927-023-00330-1.
2023
AOU Città della Salute di Torino
ASL Città di Torino
Lanzetta I; Fenoglio R; Menegatti E; Roccatello D; Charbonier N; Barreca A; Cecchi I; Sciascia S; Giarin M; Radin M; Miraglia P;
Clinical-Pathological Characteristics of Renal Injuries Identify Different Clusters in Patients With Antiphospholipid Antibodies. in Kidney international reports / Kidney Int Rep. 2023 Jan 23;8(4):754-763. doi: 10.1016/j.ekir.2023.01.018. eCollection 2023 Apr.
2023
ASL Città di Torino
AOU Città della Salute di Torino
Barreca A; Caroti L; Roccatello D; Fenoglio R; Sciascia S; De Simone E; Cecchi I; Emmi G; Cuadrado MJ; Radin M; Becker JU; Seshan SV; Andrade D; Moroni G; Yazdany J; Innocenti S;
Clinical exome sequencing as a valuable diagnostic tool for glomerulopathies: a cohort study in European Journal of Human Genetics
2023
ASL Torino 3
AOU Città della Salute di Torino
AOU Alessandria
ASL Città di Torino
Faini AC; Bracciamà V; Kalantari S; Del Prever GMB; Callegari M; Peruzzi L; Fenoglio R; Roccatello D; Vaisitti T; Amoroso A; Deaglio S;
The need for kidney biopsy in the management of side effects of target and immunotherapy. in Frontiers in nephrology / Front Nephrol. 2023 Feb 27;3:1043874. doi: 10.3389/fneph.2023.1043874. eCollection 2023.
2023
ASL Città di Torino
AOU Città della Salute di Torino
Roccatello D; Barreca A; Sciascia S; Cozzi M; Del Vecchio G; Fenoglio R; Comandone A;
Antiphospholipid Syndrome and Kidney Involvement. in Kidney & blood pressure research / Kidney Blood Press Res. 2023;48(1):666-677. doi: 10.1159/000529229. Epub 2023 Sep 21.
2023
AOU Città della Salute di Torino
ASL Città di Torino
Roccatello D; Barreca A; Fenoglio R; De Simone E; Sciascia S; Oddone V;
Recognizing the new disorder "idiopathic hypocryoglobulinaemia" in patients with previously unidentified clinical conditions. in Scientific reports / Sci Rep. 2022 Sep 1;12(1):14904. doi: 10.1038/s41598-022-18427-x.
2022
ASL Città di Torino
AOU Città della Salute di Torino
Rossi D; Fenoglio R; Viziello L; Barreca A; Solfietti L; Battaglia L; Naretto C; Sciascia S; Roccatello D;
Extrahepatic Manifestations of Chronic HBV Infection and the Role of Antiviral Therapy. in Journal of clinical medicine / J Clin Med. 2022 Oct 23;11(21):6247. doi: 10.3390/jcm11216247.
2022
ASL Città di Torino
Roccatello D; Gattei V; Sciascia S; Fenoglio R; Andreone P; Serraino D; Zanier A; Nevola R; Pozzato G; Adinolfi LE; Mazzaro C;
Renal Fibrosis in Lupus Nephritis. in International journal of molecular sciences / Int J Mol Sci. 2022 Nov 18;23(22):14317. doi: 10.3390/ijms232214317.
2022
ASL Città di Torino
Roccatello D; Rossi D; Wilson Jones G; Mancardi D; Fenoglio R; Cecchi I; Radin M; Barinotti A; Cozzi M; Sciascia S;
Dickkopf Homolog 3 (DKK3) as a Prognostic Marker in Lupus Nephritis: A Prospective Monocentric Experience. in Journal of clinical medicine / J Clin Med. 2022 May 25;11(11):2977. doi: 10.3390/jcm11112977.
2022
ASL Città di Torino
Roccatello D; Fenoglio R; Baldovino S; Rossi D; Terzolo E; Menegatti E; Cecchi I; Radin M; Barinotti A; Sciascia S;
Management of acute kidney injury in frail patients with biopsy-proven cast nephropathy: a combined approach with chemotherapy plus Supra-hemodiafiltration with post-adsorption endogenous reinfusion. in Journal of nephrology / J Nephrol. 2022 May;35(4):1243-1249. doi: 10.1007/s40620-021-01226-4. Epub 2022 Jan 4.
2022
ASL Città di Torino
Roccatello D; Di Benedetto C; Del Vecchio G; De Simone E; Ferro M; Fenoglio R; Forneris G; Pozzato M; Quattrocchio G; Murgia S;
SAFETY and EFFICACY of the INTENSIFIED B CELL DEPLETION INDUCTION THERAPY for PATIENTS with ANCA-ASSOCIATED VASCULITIS and SEVERE RENAL INJURY: A CONTROLLED STUDY in Annals of the Rheumatic Diseases
2022
AOU Città della Salute di Torino
ASL Città di Torino
Roccatello D; Sciascia S; Murgia S; Quattrocchio G; Ferro M; De Simone E; Naretto C; Barreca A; Rossi D; Fenoglio R;
Renal Involvement in Transthyretin Amyloidosis: The Double Presentation of Transthyretin Amyloidosis Deposition Disease. in Nephron / Nephron. 2022;146(5):481-488. doi: 10.1159/000522370. Epub 2022 Mar 18.
2022
ASL Città di Torino
Roccatello D; Papotti M; Sbaiz L; Sciascia S; Bottasso E; Barreca A; Baldovino S; Fenoglio R;
Non HCV-Related Mixed Cryoglobulinemic Vasculitis With Biopsy-Proven Renal Involvement: The Effects of Rituximab. in Frontiers in medicine / Front Med (Lausanne). 2022 Mar 28;9:819320. doi: 10.3389/fmed.2022.819320. eCollection 2022.
2022
ASL Città di Torino
Roccatello D; Alpa M; Naretto C; Rossi D; Sciascia S; Fenoglio R;
How the Availability of Anti-C5a Agents Could Change the Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. in Kidney & blood pressure research / Kidney Blood Press Res. 2022;47(8):506-513. doi: 10.1159/000525357. Epub 2022 Jun 3.
2022
ASL Città di Torino
Sciascia S; Oddone V; Fenoglio R; Roccatello D;
New Onset Biopsy-Proven Nephropathies after COVID Vaccination. in American journal of nephrology / Am J Nephrol. 2022;53(4):325-330. doi: 10.1159/000523962. Epub 2022 Mar 30.
2022
ASL Città di Torino
Roccatello D; Sciascia S; Del Vecchio G; De Simone E; Oddone V; Marchisio M; Lalloni S; Fenoglio R;
Renal involvement as a unique manifestation of hemophagocytic syndrome. in Frontiers in medicine / Front Med (Lausanne). 2022 Oct 5;9:796121. doi: 10.3389/fmed.2022.796121. eCollection 2022.
2022
ASL Città di Torino
AOU Città della Salute di Torino
Fenoglio R; Radin M; Quattrocchio G; Naretto C; Alpa M; Barreca A; Sciascia S; Roccatello D;
Treating Patients With ANCA-Associated Vasculitis and Very Severe Renal Injury With an Intensified B Cell Depletion Therapy: Comparison With a Control Cohort Receiving a Conventional Therapy. in Frontiers in immunology / Front Immunol. 2022 Mar 24;13:777134. doi: 10.3389/fimmu.2022.777134. eCollection 2022.
2022
ASL Città di Torino
AOU Città della Salute di Torino
Rossi D; De Simone E; Naretto C; Barreca A; Sammartino A; Roccatello D; Sciascia S; Murgia S; Quattrocchio G; Fenoglio R; Ferro M;
Clinical exome sequencing is a powerful tool in the diagnostic flow of monogenic kidney diseases: an Italian experience. in Journal of nephrology / J Nephrol. 2021 Oct;34(5):1767-1781. doi: 10.1007/s40620-020-00898-8. Epub 2020 Nov 23.
2021
ASL Cuneo 1
ASL Torino 4
AO Ordine Mauriziano
ASL Alessandria
AOU San Luigi di Orbassano
ASL VCO
AOU Città della Salute di Torino
ASL Torino 3
ASL Città di Torino
Amoroso A; Deaglio S; Roccatello D; Ungari S; Cantaluppi V; Chiappero F; Borzumati M; Bussolino S; Savoldi S; Biancone L; Vitale C; Calabrese G; Tamagnone M; Rendine S; Sciascia S; Fenoglio R; Rollino C; Baldovino S; Benvenuta C; Cocchi E; Pelle A; Togliatto G; Giachino D; Vanzino SB; Arruga F; Bracciamà V; Vaisitti T; Sorbini M; Kalantari S; et alii...
A new challenge for lupus nephritis management: Induction therapy without immunosuppressive maintenance regimen. in Autoimmunity reviews / Autoimmun Rev. 2021 Jul;20(7):102844. doi: 10.1016/j.autrev.2021.102844. Epub 2021 May 7.
2021
ASL Città di Torino
Rossi D; Fenoglio R; Sciascia S; Roccatello D;
Endothelial dysfunction and cardiovascular risk in lupus nephritis: New roles for old players? in European journal of clinical investigation / Eur J Clin Invest. 2021 Feb;51(2):e13441. doi: 10.1111/eci.13441. Epub 2020 Nov 15.
2021
ASL Città di Torino
Roccatello D; Fenoglio R; Cecchi I; Radin M; Cozzi M; Arrigo E; Mancardi D; Sciascia S;
Moving toward personalized approaches in the management of lupus nephritis. in Expert opinion on biological therapy / Expert Opin Biol Ther. 2021 Dec;21(12):1547-1550. doi: 10.1080/14712598.2022.1998449. Epub 2021 Nov
2021
ASL Città di Torino
Roccatello D; Fenoglio R; Sciascia S;
Efficacy of low or standard rituximab-based protocols and comparison to Ponticelli's regimen in membranous nephropathy. in Journal of nephrology / J Nephrol. 2021 Apr;34(2):565-571. doi: 10.1007/s40620-020-00781-6. Epub 2020 Jun 27.
2021
ASL Città di Torino
Roccatello D; Naretto C; Quattrocchio G; Ferro M; Del Vecchio G; De Simone E; Sciascia S; Baldovino S; Fenoglio R;
Cryoglobulinemic glomerulonephritis: clinical presentation and histological features, diagnostic pitfalls and controversies in the management. State of the art and the experience on a large monocentric cohort treated with B cell depletion therapy. in Minerva medica / Minerva Med. 2021 Apr;112(2):162-174. doi: 10.23736/S0026-4806.20.07076-7. Epub 2020 Nov 16.
2021
AOU Città della Salute di Torino
ASL Città di Torino
Barreca A; Roccatello D; Solfietti L; Viziello L; Kalikatzaros I; Ventrella F; Baldovino S; Kamgaing J; Ferro M; Fenoglio R; Sciascia S; Rossi D;
A Prospective Study on Long-Term Clinical Outcomes of Patients With Lupus Nephritis Treated With an Intensified B-Cell Depletion Protocol Without Maintenance Therapy. in Kidney international reports / Kidney Int Rep. 2021 Feb 3;6(4):1081-1087. doi: 10.1016/j.ekir.2021.01.027. eCollection 2021 Apr.
2021
ASL Città di Torino
Rossi D; Rahbani E; Rubini E; Quattrocchio G; Ferro M; Fenoglio R; Alpa M; Naretto C; Sciascia S; Roccatello D;
The Challenging Management of Cancer: An Immunonephrologist's Perspective. in Kidney & blood pressure research / Kidney Blood Press Res. 2021;46(1):114-120. doi: 10.1159/000511256. Epub 2020 Dec 16.
2021
AOU Città della Salute di Torino
ASL Città di Torino
Barreca A; Sciascia S; Quattrocchio G; Ferro M; Del Vecchio G; Roccatello D; De Simone E; Fenoglio R;
Renal outcome after rituximab in adult-onset IgA vasculitis and crescentic IgA nephropathy: A multicentre study in Nephrology Dialysis Transplantation
2021
ASL Città di Torino
Roccatello D; Vaglio A; Emmi G; Jayne D; Mcadoo S; Moiseev S; Farisogullari B; O'Sullivan D; Ponte C; Lamprecht P; Hocevar A; Karadag O; Little M; Harris H; Smitienko I; Eriksson P; Segelmark M; Novikov P; Nogueira E; Silvestri E; Mohammad A; Fenoglio R; Pillebout E; Trivioli G; Canzian A; Maritati F; Letizia Urban M;
Prognostic and Diagnostic Values of Novel Serum and Urine Biomarkers in Lupus Nephritis: A Systematic Review. in American journal of nephrology / Am J Nephrol. 2021;52(7):559-571. doi: 10.1159/000517852. Epub 2021 Aug 13.
2021
ASL Città di Torino
Roccatello D; Fenoglio R; Barinotti A; Miraglia P; Radin M; Sciascia S;
Towards a novel target therapy for renal diseases related to plasma cell dyscrasias: The example of AL amyloidosis. in Autoimmunity reviews / Autoimmun Rev. 2020 Sep;19(9):102622. doi: 10.1016/j.autrev.2020.102622. Epub 2020 Jul 12.
2020
ASL Città di Torino
Sciascia S; Barreca A; Rossi D; Ferro M; Naretto C; Baldovino S; Fenoglio R; Roccatello D;
Evaluation of novel assays for the detection of autoantibodies in antiphospholipid syndrome. in Autoimmunity reviews / Autoimmun Rev. 2020 Oct;19(10):102641. doi: 10.1016/j.autrev.2020.102641. Epub 2020 Aug 13.
2020
ASL Città di Torino
Mahler M; Roccatello D; Menegatti E; Fenoglio R; Baldovino S; Foddai SG; Rubini E; Cecchi I; Casas S; Bentow C; Seaman A; Ramirez C; Radin M; Sciascia S;
Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in patients with severe COVID-19. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2020 May-Jun;38(3):529-532. Epub 2020 May 1.
2020
ASL Città di Torino
Roccatello D; Oddone V; Osella S; Piccioni P; Radin M; Navarra M; Natale G; Milone V; Massara C; Manno E; Livigni S; Giusti M; Imperiale D; Imperiale G; Crosasso P; De Iaco F; Di Perri G; Eandi M; Fenoglio R; Cozzi M; Converso M; Cinnirella G; Boaro D; Boero R; Bonora S; Calcagno A; Cecchi I; Baldovino S; Rossi D; et alii...
Clinicopathologic predictors of renal outcomes in light chain cast nephropathy: a multicenter retrospective study. in Blood / Blood. 2020 May 21;135(21):1833-1846. doi: 10.1182/blood.2019003807.
2020
ASL Città di Torino
AOU Città della Salute di Torino
Santos A; Rosenblum F; Sanders PW; Rocatello D; Rennke HG; Rabant M; Pani A; Motwani SS; Manso R; Maletta F; Lepori N; Knebelmann B; Herrera GA; Goujon JM; Gougeon F; Fenoglio R; Fatima H; Drosou ME; Cohen C; Bianco P; Barreca A; Asunis AM; Alexander MP; Angioi A; Adam BA; LeBlanc R; Nasr SH; Écotière L; Troyanov S; et alii...
Rituximab in severe immunoglobulin-A vasculitis (Henoch-Schönlein) with aggressive nephritis. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2020 Mar-Apr;38 Suppl 124(2):195-200. Epub 2020 May 22.
2020
ASL Città di Torino
Roccatello D; Quattrocchio G; Ferro M; Del Vecchio G; De Simone E; Naretto C; Sciascia S; Fenoglio R;
CD38 and Anti-CD38 Monoclonal Antibodies in AL Amyloidosis: Targeting Plasma Cells and beyond. in International journal of molecular sciences / Int J Mol Sci. 2020 Jun 10;21(11):4129. doi: 10.3390/ijms21114129.
2020
ASL Città di Torino
AOU Città della Salute di Torino
Malavasi F; Baldovino S; Barreca A; Ferro M; Rossi D; Naretto C; Sciascia S; Fenoglio R; Roccatello D;
Long-term effects of intensive B cell depletion therapy in severe cases of IgG4-related disease with renal involvement. in Immunologic research / Immunol Res. 2020 Dec;68(6):340-352. doi: 10.1007/s12026-020-09163-3. Epub 2020 Nov 10.
2020
ASL Città di Torino
Roccatello D; Sciascia S; Rollino C; Massara C; Del Vecchio G; Ferro M; Fenoglio R; Barreca A; Demarchi A; Quattrocchio G;
Anti-beta-2-glycoprotein I domain 1 identifies antiphospholipid antibodies-related injuries in patients with concomitant lupus nephritis. in Journal of nephrology / J Nephrol. 2020 Aug;33(4):757-762. doi: 10.1007/s40620-019-00698-9. Epub 2020 Jan 23.
2020
ASL Città di Torino
ASL Torino 5
Roccatello D; Rubini E; Miraglia P; Besso L; Baldovino S; Rossi D; De Marchi A; Fenoglio R; Cecchi I; Sciascia S; Radin M;
Rituximab, Cyclophosphamide, and Corticosteroids for ANCA Vasculitis: The Good, the Bad, and the Ugly. in Kidney & blood pressure research / Kidney Blood Press Res. 2020;45(6):784-791. doi: 10.1159/000509608. Epub 2020 Oct 12.
2020
ASL Città di Torino
Sciascia S; Roccatello D; Fenoglio R;
Monoclonal Gammopathy of Renal Significance: Clinical and Histological Efficacy of a Bortezomib-Based Regimen. in Frontiers in medicine / Front Med (Lausanne). 2020 Dec 16;7:587345. doi: 10.3389/fmed.2020.587345. eCollection 2020.
2020
ASL Città di Torino
AOU Città della Salute di Torino
Manes M; Pini M; Pagliaro M; Ferro M; Fenoglio R; De Simone E; Del Vecchio G; Vaccarino A; Barreca A; Quattrocchio G; Roccatello D;
Percutaneous renal biopsy in frail and high-risk patients in Journal of the American Society of Nephrology
2020
ASL Città di Torino
Fenoglio R; Sciascia S; Roccatello D;
Anticoagulation in patients with concomitant lupus nephritis and thrombotic microangiopathy: a multicentre cohort study. in Annals of the rheumatic diseases / Ann Rheum Dis. 2019 Jul;78(7):1004-1006. doi: 10.1136/annrheumdis-2018-214559. Epub 2018 Dec 14.
2019
ASL Città di Torino
Roccatello D; Papotti M; Schreiber K; Barreca A; Cuadrado MJ; Aggarwal I; Radin M; Fenoglio R; Dall'Era M; Yazdany J; Sciascia S;
The cyclophosphamide-sparing role of an intensified b-cells depletion protocol in anca-associated vasculitis in Annals of the Rheumatic Diseases
2019
ASL Città di Torino
Roccatello D; Sciascia S; Fenoglio R; Rossi D;
Percutaneous native renal biopsy as a safe procedure in outpatient with systemic autoimmune diseases: A monocentric cohort in Nephrology Dialysis Transplantation
2019
ASL Città di Torino
Roccatello D; Fenoglio R; Sciascia S;
Efficacy of low or standard dose rituximab as compared to Ponticelli's regimen in membranous nephropathy in Nephrology Dialysis Transplantation
2019
ASL Città di Torino
Roccatello D; Fenoglio R; Sciascia S;
Optimization of the evaluation of total kidney volume in autosomal dominant polycystic kidney disease (ADPKD) in Nephrology Dialysis Transplantation
2019
ASL Città di Torino
Giulio DV; Fenoglio R; Roccatello D;
The cyclophosphamide-sparing effect of an intensified B-cells depletion protocol in ANCA-associated vasculitis: A case-control study in Nephrology Dialysis Transplantation
2019
ASL Città di Torino
Roccatello D; Fenoglio R; Sciascia S;
Membranous nephropathy: efficacy of low or standard rituximab-based protocols and comparison to the ponticelli regimen in Journal of the American Society of Nephrology
2019
ASL Città di Torino
Fenoglio R; Sciascia S; Roccatello D;
Autosomal dominant polycystic kidney disease (ADPKD): Optimization of the evaluation of total kidney volume in Journal of the American Society of Nephrology
2019
ASL Città di Torino
Fenoglio R; Sciascia S; Roccatello D;
Lung cancer and renal failure in Journal of the American Society of Nephrology
2019
ASL Città di Torino
Fenoglio R; Sciascia S; Roccatello D;
ASIA Syndrome Following Breast Implant Placement. in The Israel Medical Association journal : IMAJ
2018
ASL Città di Torino
Fenoglio R; Cecchi I; Roccatello D;
Rituximab as a front-line therapy for adult-onset minimal change disease with nephrotic syndrome. in Oncotarget / Oncotarget. 2018 Jun 22;9(48):28799-28804. doi: 10.18632/oncotarget.25612. eCollection 2018 Jun 22.
2018
ASL Città di Torino
Roccatello D; Menegatti E; Ferro M; Quattrocchio G; Mesiano P; Beltrame G; Fenoglio R; Sciascia S;
IgG4-related kidney disease: the effects of a Rituximab-based immunosuppressive therapy. in Oncotarget / Oncotarget. 2018 Apr 20;9(30):21337-21347. doi: 10.18632/oncotarget.25095. eCollection 2018 Apr 20.
2018
ASL Città di Torino
Massara C; Del Vecchio G; Murgia S; Mesiano P; Ferro M; Fenoglio R; Beltrame G; Solfietti L; Demarchi A; Barreca A; Quattrocchio G; Rollino C; Roccatello D;
The cyclophosphamide-sparing role of an intensified b-cells depletion protocol in anca-associated vasculitis: A case-control study in Journal of the American Society of Nephrology
2018
ASL Città di Torino
Fenoglio R; Sciascia S; Roccatello D;
Clinical outcomes and response to anti-thrombotic treatment among patients with concomitant lupus nephritis and thrombotic microangiopathy: A multicentre cohort study in Journal of the American Society of Nephrology
2018
ASL Città di Torino
Sciascia S; Fenoglio R; Roccatello D;
The challenge of treating hepatitis C virus-associated cryoglobulinemic vasculitis in the era of anti-CD20 monoclonal antibodies and direct antiviral agents. in Oncotarget / Oncotarget. 2017 Jun 20;8(25):41764-41777. doi: 10.18632/oncotarget.16986.
2017
ASL Città di Torino
Menegatti E; Fenoglio R; Solfietti L; Rossi D; Sciascia S; Roccatello D; Baldovino S;
Acute renal infarction: a single center experience. in Journal of nephrology / J Nephrol. 2017 Feb;30(1):103-107. doi: 10.1007/s40620-015-0259-0. Epub 2016 Jan 7.
2017
ASL Città di Torino
Macchia G; Roccatello D; Bazzan M; Forneris G; Cecere P; Pozzato M; Fenoglio R; Quattrocchio G; Ferro M; Beltrame G; Rollino C; Mesiano P;
Rituximab therapy for IgA-vasculitis with nephritis: a case series and review of the literature. in Immunologic research
2017
ASL Città di Torino
Fenoglio R; Naretto C; Basolo B; Quattrocchio G; Ferro M; Mesiano P; Beltrame G; Roccatello D;
Chronic kidney disease and anticoagulation: from vitamin K antagonists and heparins to direct oral anticoagulant agents. in Internal and emergency medicine / Intern Emerg Med. 2017 Dec;12(8):1101-1108. doi: 10.1007/s11739-017-1753-2. Epub 2017 Sep 19.
2017
ASL Città di Torino
Fenoglio R; Baldovino S; Radin M; Schreiber K; Sciascia S; Roccatello D;
The "4 plus 2" rituximab protocol makes maintenance treatment unneeded in patients with refractory ANCA-associated vasculitis: A 10 years observation study. in Oncotarget / Oncotarget. 2017 May 23;8(32):52072-52077. doi: 10.18632/oncotarget.18120. eCollection 2017 Aug 8.
2017
ASL Città di Torino
Menegatti E; Baldovino S; Fenoglio R; Radin M; Naretto C; Alpa M; Sciascia S; Rossi D; Roccatello D;
Bevacizumab: Renal Safety Evaluation in Journal of Onco-Nephrology
2017
ASL Città di Torino
Fenoglio R; Roccatello D;
High-Dose Rituximab Ineffective for Focal Segmental Glomerulosclerosis: A Long-Term Observation Study in American Journal of Nephrology
2017
ASL Città di Torino
Roccatello D; Sciascia S; Rossi D; Alpa M; Naretto C; Radin M; Barreca A; Fenoglio R; Baldovino S; Menegatti E;
High doses of rituximab are ineffective in adult patients with focal segmental glomerulosclerosis in Journal of the American Society of Nephrology
2017
ASL Città di Torino
Roccatello D; Sciascia S; Fenoglio R;
Safety profile of outpatient percutaneous native renal biopsy: A large monocentric single operator cohort in Journal of the American Society of Nephrology
2017
ASL Città di Torino
Roccatello D; Sciascia S; Fenoglio R;
Effects of high titers of anti-chimeric antibodies following rituximab in Journal of the American Society of Nephrology
2017
ASL Città di Torino
Roccatello D; Sciascia S; Fenoglio R;
Timing the effect of rituximab on peripheral CD 20+b cells: An in vivo experience in Journal of the American Society of Nephrology
2017
ASL Città di Torino
Roccatello D; Sciascia S; Fenoglio R;
Effects of rituximab in adult patients with minimal change disease in Journal of the American Society of Nephrology
2017
ASL Città di Torino
Roccatello D; Sciascia S; Fenoglio R;
New insights into immune mechanisms underlying response to Rituximab in patients with membranous nephropathy: A prospective study and a review of the literature. in Autoimmunity reviews / Autoimmun Rev. 2016 Jun;15(6):529-38. doi: 10.1016/j.autrev.2016.02.014. Epub 2016 Feb 11.
2016
ASL Città di Torino
Menegatti E; Baldovino S; Fenoglio R; Naretto C; Solfietti L; Di Simone D; Sciascia S; Roccatello D;
Impact of pre-transplant antiaggregant and anticoagulant therapies on early hemorrhagic and cardiovascular events after kidney transplantation. in Journal of nephrology / J Nephrol. 2015 Dec;28(6):757-64. doi: 10.1007/s40620-015-0185-1. Epub 2015 Mar 6.
2015
ASL Città di Torino
AOU Città della Salute di Torino
Cena T; Quaglia M; Musetti C; Stratta P; Lazzarich E; Battista M; Fenoglio R;